home / stock / kprx / kprx news

KPRX News and Press, Kiora Pharmaceuticals Inc. From 09/18/23

Stock Information
Company Name: Kiora Pharmaceuticals Inc.
Stock Symbol: KPRX
Market: NASDAQ
Website: kiorapharma.com
Menu
KPRX KPRX Quote KPRX Short KPRX News KPRX Articles KPRX Message Board
Get KPRX Alerts

News, Short Squeeze, Breakout and More Instantly...
KPRX - Kiora Pharmaceuticals Completes Last Patient, Last Visit in Phase 1B Trial of KIO-301 in Patients with Retinitis Pigmentosa

Encinitas, California--(Newsfile Corp. - September 18, 2023) - Kiora Pharmaceuticals (NASDAQ: KPRX) today announced the completion of the final patient's last endpoint evaluation from the ABACUS study of KIO-301. KIO-301 is A molecular photoswitch being evaluated in a Phase 1B clinical trial for ...
KPRX - Kiora Pharmaceuticals to Present Topline Results from the ABACUS Study at American Academy Ophthalmology (AAO); Phase 1b Study Evaluating KIO-301 in Retinitis Pigmentosa

Encinitas, California--(Newsfile Corp. - September 14, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") announced that results from the ABACUS study of KIO-301 in patients with late-stage retinitis pigmentosa will be presented at the American Academy of Ophthalmolo...

KPRX - Kiora Pharmaceuticals Adjourns Special Meeting of Stockholders to September 27

Encinitas, California--(Newsfile Corp. - September 1, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") announced that the Company's Special Meeting of Stockholders (the "Special Meeting") held on August 31, 2023 at 9:00 a.m. Pacific Time was convened and adjourned, wi...

KPRX - Kiora Pharmaceuticals and the Choroideremia Research Foundation to Host Webinar on the Development of Molecular Photoswitches for Inherited Retinal Diseases

Live Event to be Held Thursday, August 31, at 7:30 pm Eastern Time Encinitas, California--(Newsfile Corp. - August 29, 2023) - Kiora Pharmaceuticals (NASDAQ: KPRX) invites you to participate in a webinar highlighting the progress of molecular photoswitches in retinitis pigmentosa and the futur...
KPRX - Nikola Preps for Resale of 10 Million Shares of NKLA Stock

2023-08-23 10:28:02 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Nikola (NASDAQ: NKLA ) stock is a hot topic among traders on Wednesday after the electric vehicle (EV) company revealed the reselling of its shares. According to a filing ...

KPRX - MNK Stock Alert: Mallinckrodt Files for Bankruptcy Again

2023-08-23 10:10:20 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Mallinckrodt (NYSEMKT: MNK ) stock isn’t doing so hot on Wednesday after the pharmaceutical company gets ready for another bankruptcy filing. A press release from M...

KPRX - Why Is Kiora Pharmaceuticals (KPRX) Stock Up 11% Today?

2023-08-23 09:54:27 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Kiora Pharmaceuticals (NASDAQ: KPRX ) stock is getting a boost on Wednesday after the company revealed new patents in the U.S. and Europe. According to a press release f...
KPRX - Kiora Pharmaceuticals Granted U.S. and European Patents for Local Ocular Delivery of the KIO-100 Family of Compounds; New IP Specifically Includes Treatment of Posterior Non-Infectious Uveitis

Encinitas, California--(Newsfile Corp. - August 23, 2023) - Kiora Pharmaceuticals, Inc . (NASDAQ: KPRX) ("Kiora" or the "Company") today announced it has been granted U.S. (Patent # 11,730,716) and European Patents covering local ocular delivery of the KIO-100 family of non-steroidal, anti-inf...

KPRX - Kiora Pharmaceuticals Taps B2i Digital to Deploy Data-Driven Investor Awareness Program

Encinitas, California--(Newsfile Corp. - August 22, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), a clinical-stage biotechnology company developing novel therapies for the treatment of ophthalmic diseases, today announced it has partnered with B2i Digital, Inc. to execute a comprehensive di...

KPRX - Kiora Pharmaceuticals Webcasts Its Investor Presentation from the H.C. Wainwright 3rd Annual Ophthalmology Virtual Conference

Encinitas, California--(Newsfile Corp. - August 16, 2023) - Kiora Pharmaceuticals (NASDAQ: KPRX) welcomes investors to watch the Company's online presentation from the H.C. Wainwright 3 rd Annual Ophthalmology Virtual Conference. As part of the talk, Kiora President & CEO Brian Strem, Ph.D...
Previous 10 Next 10